Allergan shares fell the most in 21 months after sales of Botox missed analysts’ estimates.

New York/Westport: Allergan, the maker of Botox, said second-quarter profit rose 2.7% and raised its earnings forecast on higher sales of the wrinkle smoother and breast implants.